- Integer Holdings Corporation ITGR posted Q3 sales of $305.57 million, +30% Y/Y, beating the consensus of $303.23 million. Q3 adjusted EPS more than doubled to $1.05, ahead of the consensus of $0.84.
- Adjusted operating income expanded 86% to $47 million, while adjusted EBITDA improved 63% to $60 million.
- Integer also agreed to acquire Oscor Inc, a privately held medical device company, for $220 million. Oscor broadens Integer's product portfolio, expands its R&D capabilities, and adds low-cost manufacturing capacity.
- The transaction is expected to be accretive EPS in 2022, increasing Integer's EPS growth rate by low-single-digit.
- Integer announced the construction of a manufacturing facility in Ireland. The Company expects to spend approximately $30 million over five years on the facility.
- Guidance: Integer expects FY21 sales of $1.205 billion - $1.22 billion, compared to earlier guidance of $1.20 billion - $1.22 billion.
- The Company raised adjusted EPS guidance to $3.90 - $4.15 (consensus $3.88) from $3.66 - $4.03 expected earlier.
- Price Action: ITGR shares are up 2.30% at $93.60 during the market session on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in